Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 2071535 | Danicopan | 1903768-17-1 | ≧98.0% |  |
| Danicopan, aslo known as ACH-4471 and ACH-0144471, is a highly potent, orally active | ||||
| 191123 | Tafenoquine succinate | 106635-81-8 | >98% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 52007 | SRT1720 | 1001645-58-4 | 98% |  |
| SRT1720 is a selectiveSIRT1activator withEC50of 0.16 M, but is >230-fold less pote | ||||
| 19381 | Abrocitinib | 1622902-68-4 | >98% |  |
| Abrocitinib, Bulk in stock, contact us by email for the quotation. Kg scale intermedi | ||||
| 20294 | Paltusotine ( CRN-00808 ) | 2172870-89-0 | ≧98.0% | _2172870-89-0.png) |
| Paltusotine is a new class of oral, selective, nonpeptide, somatostatin receptor type | ||||
| 51703 | Luminespib ( NVP-AUY922 ; VER-52296 ) | 747412-49-3 | 98% | _747412-49-3.png) |
| NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc | ||||
| 51902 | AT13148 | 1056901-62-2 | ≧98% |  |
| AT13148, a first-in-class multi-AGC kinase inhibitor, against gastric cancer cells. A | ||||
| 51702 | AZD1208 | 1204144-28-4 | 98% |  |
| AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor that | ||||
| 51603 | AZD6482 | 1173900-33-8 | ≧98.0% |  |
| AZD6482 is aPI3Kinhibitor withIC50of 10 nM, 8-, 87- and 109-fold more selective to PI | ||||
| 51905 | CPI-613(Devimistat ) | 95809-78-2 | ≧98.0% |  |
| CPI-613( Devimistat ) is an E1 pyruvate dehydrogenase (PDH) modulator that prevents c | ||||
| 52023 | DCC-2036(Rebastinib) | 1020172-07-9 | 98% | _1020172-07-9.png) |
| Rebastinib(DCC-2036;DCC2036) is an inhibitor of tyrosine kinases TIE2 and ABL1.Rebast | ||||
| 52019 | GSK 2656157 | 1337532-29-2 | 98% |  |
| GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9 | ||||